Literature DB >> 11214045

Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment.

J J von Lindern1, B Niederhagen, T Appel, S Bergé, R H Reich.   

Abstract

The treatment of hypertrophy of the masseter and temporal muscles has to date been dominated by conservative and surgical measures. Local therapy with type A botulinum toxin permits an alternative method of treatment. After targeted, sometimes electromyographically controlled, intramuscular injection of the affected muscles, marked inactivity atrophy occurred in the muscles of seven patients over the course of 3 to 8 weeks. This atrophy remained constant over a follow-up period of up to 25 months, and no side effects were observed. Because of its minimal invasiveness, this technique seems to have an advantage over conventional surgical therapy. Consequently, treatment with type A botulinum toxin can be regarded as a sensible alternative to surgery in cases of hypertrophy of the masseter and/or temporal muscles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11214045     DOI: 10.1097/00006534-200102000-00004

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

1.  [Chemodenervation with botulinumtoxin in masseteric hypertrophy].

Authors:  R A Mischkowski; M Siessegger; F Lazar; J E Zöller
Journal:  Mund Kiefer Gesichtschir       Date:  2005-03

Review 2.  Botulinum toxin for masseter hypertrophy.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2013-09-09

Review 3.  Botulinum toxin in the treatment of muscle specific Oro-facial pain: a literature review.

Authors:  C Sunil Dutt; Pooja Ramnani; Deepak Thakur; Manish Pandit
Journal:  J Maxillofac Oral Surg       Date:  2014-09-04

4.  Botox Therapy for Hypertrophy of the Masseter Muscle Causes a Compensatory Increase of Stiffness of Other Muscles of Masticatory Apparatus.

Authors:  Dorota Mierzwa; Cyprian Olchowy; Anna Olchowy; Izabela Nawrot-Hadzik; Paweł Dąbrowski; Sławomir Chobotow; Kinga Grzech-Leśniak; Paweł Kubasiewicz-Ross; Marzena Dominiak
Journal:  Life (Basel)       Date:  2022-06-06

5.  Ultrastructural evaluation of intramuscular applied botulinum toxin type A in striated muscles of rats.

Authors:  H Kocaelli; M Yaltirik; M Ayhan; F Aktar; B Atalay; S Yalcin
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

6.  Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.

Authors:  Fernanda Homem de Mello de Souza Klein; Fabiane Mulinari Brenner; Maurício Shigeru Sato; Fernanda Manfron Batista Rosas Robert; Karin Adriane Helmer
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

7.  Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation.

Authors:  Young-Min Moon; Young-Jun Kim; Min-Keun Kim; Seong-Gon Kim; HaeYong Kweon; Tae-Woo Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-12-29

8.  Apoptotic action of botulinum toxin on masseter muscle in rats: early and late changes in the expression of molecular markers.

Authors:  Young-Min Moon; Min-Keun Kim; Seong-Gon Kim; Tae-Woo Kim
Journal:  Springerplus       Date:  2016-07-07

9.  S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection.

Authors:  Young-Wook Park; Seong-Gon Kim; You-Young Jo
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-08-26

Review 10.  Isolated unilateral temporalis muscle hypertrophy in a child: a case report with literature review.

Authors:  Jagath C Ranasinghe; Chandani Wickramasinghe; Ganganath Rodrigo
Journal:  BMC Pediatr       Date:  2018-02-19       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.